MABVAX THERAPEUTICS HOLDINGS, INC. 3 SEC Filings

Filed On	Filing
22 Mar 2016	Form 3: Resnick Paul F, Vice President, CBO
29 Feb 2016	Form 3: Eisenberg Jeffrey F, Director
08 Apr 2015	Form 3: Varvaro Thomas C, Director Holds 34,250 shares of Restricted Common Stock
03 Oct 2014	Form 3: Maffuid Paul W, (2)
12 Sep 2014	Form 3: Hoffman Robert, Director
18 Jul 2014	Form 3: Biomark Capital Fund Iv Lp, 10% owner and 2 others Holds 1,581,129 shares of Common Stock
17 Jul 2014	Form 3: Scholz Wolfgang W., VP of Antibody Discovery Holds 400,192 shares of Common Stock
17 Jul 2014	Form 3: Ravetch Jeffrey V., Director
17 Jul 2014	Form 3: Maier Paul V, Director
17 Jul 2014	Form 3: Livingston Philip O., Director Holds 881,181 shares of Common Stock
17 Jul 2014	Form 3: Hanson Gregory P, Chief Financial Officer
17 Jul 2014	Form 3: Hansen John David, Director Holds 533,589 shares of Common Stock
17 Jul 2014	Form 3: Cohen Kenneth M, Director
17 Jul 2014	Form 3: Antonopoulos Jim J., Director
29 Dec 2010	Form 3: Wee Wendy, Principal Financial Officer & Holds 22,273 shares of Common Stock
18 May 2010	Form 3: Schow Steven R, Vice President, Research Holds 31,381 shares of Common Stock
10 Jan 2008	Form 3: Eastbourne Capital Management LLC/CA, 10% owner Holds 15,736,019 shares of Common Stock
27 Feb 2006	Form 3: Black Bear Offshore Master Fund Lp, 10% owner Holds 5,222,675 shares of Common Stock
07 Oct 2005	Form 3: Kaplan William Phillip, VP, Legal Affairs Holds 1,960 shares of Common Stock
27 Aug 2004	Form 3: Steuer Marc, SVP - Business Development

Comments